Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCP-Tacro vs Prograf in De Novo Liver Transplant
NCT00772148Phase 2Completed
- Sponsor
- Veloxis Pharmaceuticals
- Start
- Oct 2008
- Primary completion
- May 2010
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Envarsus XR in Liver transplant rejection, sponsored by Veloxis Pharmaceuticals. Started Oct 2008; status: completed.
02
Drugs
Envarsus XR
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT00772148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00772148.